Unusual features of apical hypertrophic cardiomyopathy

Tommy Chung1, John Yiannikas, Saul Ben Freedman

  • 1Department of Cardiology, Concord Hospital, University of Sydney, Sydney, Australia. twc.chung@gmail.com

Insights

Apical hypertrophic cardiomyopathy (HC) in elderly Caucasians presents differently than in Japanese men. This condition can evolve late, with significant risks including coronary fistulae and atrial fibrillation.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Apical hypertrophic cardiomyopathy (HC) is often considered benign in young to middle-aged Japanese men.
  • Its characteristics in predominantly Caucasian, elderly populations are less understood.

Purpose of the Study:

  • To describe the cardiovascular characteristics, morbidity, and mortality of elderly, predominantly Caucasian patients with apical HC.
  • To investigate the late evolution and associated conditions of apical HC in this demographic.

Main Methods:

  • Retrospective analysis of 32 consecutive patients with apical HC (mean age 71 years).
  • Review of medical records, electrocardiography, echocardiography, and coronary angiography.
  • Identification of coexistent conditions and clinical outcomes.

Main Results:

  • The cohort was predominantly Caucasian (23/32) and elderly (mean age 71), with 22 patients having coexistent hypertension.
  • Late morphologic evolution of apical HC was observed in 6 patients.
  • Associated conditions included coronary artery fistulae (6/13), atrial fibrillation (10/32) with thromboembolic events (6/10), and exertional syncope requiring an implantable defibrillator (1/32).
  • Mortality (6/32) was linked to stroke and heart failure.

Conclusions:

  • Apical HC in a predominantly Caucasian, elderly population presenting at a general teaching hospital differs from the typical profile.
  • Late morphologic changes, coronary fistulae, and significant morbidity from atrial fibrillation are notable.
  • Awareness and appropriate diagnostic evaluation are crucial, as initial diagnosis can be missed.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...